Lithium Orotate vs Selank for anxiety
Short answer: For anxiety, users rate them about the same: 98% report improvement with Lithium Orotate (80 reports) and 97% with Selank (112 reports).
Lithium Orotate has 581 meta-analyses and 979 randomized trials on PubMed; Selank has 0 and 2.
Based on 307 reports about Lithium Orotate and 383 about Selank. Not medical advice.
| Lithium Orotate Supplement | Selank Peptide | |
|---|---|---|
| Users say it helped | 76%helped138 reports · high confidence | 75%helped138 reports · high confidence |
| Verdict | Mostly positive | Mostly positive |
| Research | AResearch: Strong | CResearch: Limited |
| Meta-analyses / RCTs | 581 / 979 | 0 / 2 |
| Mainly used for | ||
| Anxiety % reporting improvement | 98% (80) | 97% (112) |
| Mood % reporting improvement | 92% (108) | 90% (39) |
| Focus % reporting improvement | 81% (16) | 86% (36) |
| Sleep % reporting improvement | 100% (16) | 90% (10) |
| Memory % reporting improvement | 100% (3) | 100% (9) |
| Common side effects | brain fog, emotional blunting, sexual dysfunction, drowsiness | headache, tolerance, injection site, tingling |
| Typical dose reported | 1-2 tablets | Not listed |
Although it is yet to be determined which is more effective between lithium or lecanemab or donanemab, lithium may be more effective than aducanumab. Aducanumab, lecanemab and donanemab do not appear to differ in their effectiveness on cognitive function. Low-dose lithium may be safer than aducanumab, lecanemab and donanemab.
Ageing Res Rev, 2024 ↗“The lithium is absolutely curbing my mania... My social anxiety is 100% gone when I take lithium orotate.”
“Selank has improved my anxiety immensely, and am able to focus on things clearly.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate